文献速递流行病学与生物统计临床试验与 GCP

纳入非劣效与等效试验的Meta分析:忽视试验设计可能导致不同且可能误导的结论

Meta-analysis of noninferiority and equivalence trials: ignoring trial design leads to differing and possibly misleading conclusions.
PubMed 文献 · J Clin Epidemiol · 2020-06-12

该研究通过Scopus识别纳入非劣效或等效(NI/EQ)试验的Meta分析,共38项Meta分析、515项RCT(其中125项为NI/EQ试验)。仅1项(2.6%)使用NI/EQ界值解读合并估计,无一项评估NI/EQ试验特有偏倚风险;用NI/EQ界值重新解读30个结局的Meta分析,多数(66.7%)与原文结论冲突。

要点

  • 多数纳入NI/EQ试验的Meta分析未报告试验设计或评估其特有偏倚风险。
  • 仅2.6%的Meta分析使用NI/EQ界值解读合并估计。
  • 用NI/EQ界值重新解读后,66.7%的结局结论与原文冲突。

核心结论

  • 大多数纳入NI/EQ试验的Meta分析忽视试验设计,未评估NI/EQ研究特有偏倚风险。
  • 针对曾以NI/EQ探讨的问题,应进行NI/EQ Meta分析或使用清晰语言进行标准(优效性)Meta分析。

研究设计与样本

  • 通过Scopus识别纳入NI/EQ试验的Meta分析,提取Meta分析及其纳入RCT的数据。
  • 共纳入38项独特Meta分析,包含515项RCT,其中125项(24.3%)为NI/EQ试验。

主要发现

  • 无一项Meta分析评估NI/EQ试验特有偏倚风险。
  • 纳入的NI/EQ试验中,116项(92.8%)报告了NI/EQ界值。
  • 对30个结局用NI/EQ界值重新解读,20个(66.7%)与Meta分析原文结论冲突。

临床怎么用

  • 针对曾以NI/EQ探讨的临床问题,Meta分析应进行NI/EQ分析或明确使用优效性框架语言。
  • 解读纳入NI/EQ试验的Meta分析时,需关注是否使用NI/EQ界值及评估特有偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study is to examine the analytic approach of meta-analyses that include noninferiority or equivalence (NI/EQ) trials. STUDY DESIGN AND SETTING: We used Scopus to identify meta-analyses including NI/EQ trials. We extracted data from the meta-analyses and their included randomized clinical trials (RCTs). We used the RCT's NI/EQ margins to reinterpret the results of the meta-analyses, assessed for risk of biases unique to NI/EQ trials, and evaluated the consistency of the meta-analysis interpretation when using NI/EQ margins. RESULTS: We identified 38 unique meta-analyses including 515 RCTs, of which 125 (24.3%) were NI/EQ trials. Fourteen meta-analyses (36.8%) reported the study design of their included trials, but only one (2.6%) interpreted their pooled estimates using NI/EQ margins and none assessed for risks of bias unique to NI/EQ trials. Nearly all NI/EQ trials (n = 116, 92.8%) included in the meta-analyses reported NI/EQ margins. The meta-analyses of 30 outcomes were reinterpreted using the NI/EQ margins; reinterpretations conflicted with the conclusion of the meta-analyses in most cases (n = 20, 66.7%). CONCLUSION: Most meta-analyses including NI/EQ trials ignore trial design and do not assess risks of bias unique to NI/EQ studies. Meta-analyses addressing questions previously explored as NI/EQ should conduct an NI/EQ meta-analysis or use clear language when performing standard (i.e., superiority) meta-analyses.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Acuna SA, Dossa F, Baxter N, et al. Meta-analysis of noninferiority and equivalence trials: ignoring trial design leads to differing and possibly misleading conclusions. J Clin Epidemiol. 2020. PMID: 32540386. doi:10.1016/j.jclinepi.2020.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。